NAVLE Cardiovascular

Canine Cardiopulmonary Arrest – NAVLE Study Guide

Cardiopulmonary arrest (CPA) is the sudden cessation of effective cardiac and respiratory function, resulting in loss of consciousness and the absence of a palpable pulse.

Overview and Clinical Importance

Cardiopulmonary arrest (CPA) is the sudden cessation of effective cardiac and respiratory function, resulting in loss of consciousness and the absence of a palpable pulse. This life-threatening emergency requires immediate intervention through cardiopulmonary resuscitation (CPR) to restore circulation and oxygenation. Understanding the pathophysiology, recognition, and evidence-based management of CPA is essential for the NAVLE, as it represents one of the most critical emergency scenarios encountered in veterinary practice.

Despite advances in veterinary medicine, survival to discharge after CPA remains low, with only 5 to 7 percent of dogs surviving to hospital discharge. However, dogs experiencing CPA during anesthesia have significantly better outcomes, with up to 17 times higher survival rates when CPR is initiated promptly. The 2024 RECOVER (Reassessment Campaign on Veterinary Resuscitation) guidelines provide the current evidence-based framework for CPR in dogs and cats.

Please look at RECOVER CPR Algorithm for Dogs and Cats

Category Common Causes
Cardiac Dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), severe arrhythmias (ventricular fibrillation, asystole), pericardial effusion with tamponade, myxomatous mitral valve disease with acute rupture
Respiratory Severe pneumonia, pulmonary thromboembolism, airway obstruction, pleural effusion, pneumothorax, drowning, aspiration
Anesthetic Anesthetic overdose, vagal reflex, hypotension, hypoxemia, hypoventilation, malignant hyperthermia
Trauma Blunt force trauma, hemorrhage, tension pneumothorax, diaphragmatic hernia, head trauma
Metabolic/Systemic Severe electrolyte abnormalities (hyperkalemia, hypocalcemia), septic shock, hypovolemic shock, gastric dilatation-volvulus (GDV), severe hypoglycemia, hypothermia
Toxicologic Cardiotoxins (digitalis, calcium channel blockers, beta-blockers), respiratory depressants (opioids, barbiturates), organophosphates

Etiology and Pathophysiology

Common Causes of Cardiopulmonary Arrest

Cardiopulmonary arrest in dogs is typically multifactorial and can result from numerous underlying conditions. Unlike humans, where coronary artery disease is the predominant cause, CPA in dogs more commonly results from progressive systemic illness, trauma, or anesthetic complications.

High-YieldOn the NAVLE, remember that dogs experiencing CPA during anesthesia have a 17 times higher survival rate compared to non-anesthetic causes. This is because immediate intervention is available and reversible causes (vagal stimulation, drug overdose) can be quickly addressed.

Pathophysiologic Mechanisms

Cardiopulmonary arrest results in immediate cessation of blood flow and oxygen delivery to vital organs. The pathophysiologic cascade includes:

  • Global tissue ischemia: Within seconds of CPA, cerebral blood flow ceases, leading to loss of consciousness. Brain cells begin to die within 4 to 6 minutes without oxygen.
  • Metabolic acidosis: Anaerobic metabolism leads to lactate accumulation and severe acidemia. Normal lactate is less than 2 mmol per L; levels often exceed 10 mmol per L during CPA.
  • Sympathetic response: Initial intense sympathetic stimulation causes peripheral vasoconstriction, but the vasomotor center fails after 10 to 15 minutes without perfusion.
  • Post-cardiac arrest syndrome: Even after return of spontaneous circulation (ROSC), multiorgan dysfunction persists, including myocardial stunning, systemic inflammatory response, and reperfusion injury.

Cardiac Arrest Rhythms

The terminal cardiac rhythm present during CPA determines treatment strategy. In veterinary medicine, approximately 61 percent of dogs present with non-shockable rhythms.

(Figure 1) - ECG tracings showing asystole, PEA, ventricular fibrillation, and pulseless VT

Rhythm ECG Characteristics Treatment Approach
Asystole Flat line with no electrical activity. Most common terminal rhythm in small animals. NON-SHOCKABLE: Continue CPR, administer epinephrine every 3-5 minutes, single dose atropine may be considered
Pulseless Electrical Activity (PEA) Organized electrical complexes at rate less than 200 per minute but no palpable pulse NON-SHOCKABLE: Continue CPR, treat underlying cause (hypovolemia, tension pneumothorax, tamponade), epinephrine
Ventricular Fibrillation (VF) Chaotic, disorganized ventricular activity with no effective contractions. Irregular waveforms of varying amplitude. SHOCKABLE: Defibrillation is priority. If less than 4 minutes duration, defibrillate immediately. If greater than 4 minutes, perform 2-minute BLS cycle first, then defibrillate.
Pulseless Ventricular Tachycardia Wide, bizarre QRS complexes at rate greater than or equal to 200 per minute without pulse SHOCKABLE: Treat same as VF - defibrillation indicated

Recognition and Diagnosis of Cardiopulmonary Arrest

Clinical Signs

Rapid recognition of CPA is critical for survival. The 2024 RECOVER guidelines emphasize that CPR should be initiated within 10 to 15 seconds of recognizing CPA.

Primary signs of CPA:

  • Unresponsiveness: No response to verbal or physical stimulation
  • Absent or agonal breathing: No chest wall movement or irregular gasping breaths
  • No palpable pulse: However, pulse palpation is unreliable and should NOT delay CPR initiation
  • Dilated pupils: May occur but is not required for diagnosis
  • Cyanotic or pale mucous membranes: Poor tissue perfusion
NAVLE TipThe 2024 RECOVER guidelines specifically state that pulse palpation is NOT recommended for diagnosing CPA because it is unreliable and delays CPR. If a dog is unresponsive and not breathing (or only showing agonal gasps), START CPR immediately without checking for a pulse. This is a testable concept on the NAVLE.

Initial Assessment Algorithm

The RECOVER CPR Initial Assessment Algorithm provides a systematic approach to CPA recognition:

  • Stimulate: Shake and shout to assess responsiveness
  • Check breathing: Look for chest wall movement
  • If not breathing or only agonal gasps: Call for help and begin CPR
  • Do NOT: Waste time checking pulse or performing extensive diagnostics
Patient Type Position and Technique Compression Depth
Small Dogs and Cats (under 10 kg) LATERAL recumbency. Three technique options: 1. Circumferential two-thumb technique: Both thumbs over heart 2. One-handed technique: Thumb on one side, fingers on other 3. Heel of hand technique One-third to one-half of chest width
Medium to Giant Dogs (over 10 kg) LATERAL recumbency. Hands interlocked over widest part of chest. Rescuer shoulders directly above hands, elbows locked, using core muscles for compressions. One-third to one-half of chest width
Wide-Chested Dogs (Bulldogs, etc.) DORSAL recumbency. Start in lateral until intubated, then transition to dorsal. Hands stacked on mid-sternum. NEW 2024: One-quarter (25 percent) of chest depth to avoid overcompression and rib fractures

Basic Life Support (BLS)

Basic Life Support consists of chest compressions and ventilation to maintain minimal blood flow and oxygenation until advanced interventions can be implemented. The 2024 RECOVER guidelines include several important updates to BLS techniques.

Chest Compressions

High-quality, uninterrupted chest compressions are the cornerstone of successful CPR. Even ideal compressions only achieve approximately 30 percent of normal cardiac output.

Critical compression parameters:

  • Rate: 100 to 120 compressions per minute
  • Cycle length: Uninterrupted 2-minute cycles
  • Compressor rotation: Rotate compressor every 2 minutes to prevent fatigue
  • Full recoil: Allow complete chest wall recoil between compressions
  • Minimize interruptions: Hands-off time should be less than 10 seconds per 2-minute cycle

Ventilation

Effective ventilation maintains oxygenation and removes carbon dioxide. The 2024 RECOVER guidelines prioritize bag-mask ventilation over mouth-to-snout for non-intubated patients due to zoonotic disease concerns.

Intubated patients:

  • Rate: 10 breaths per minute (one breath every 6 seconds)
  • Tidal volume: 10 mL per kg
  • Inspiratory time: 1 second
  • Oxygen: 100 percent oxygen is reasonable, though room air may also be considered
  • Peak airway pressure: 30 to 40 cm H2O if using anesthesia circuit

Non-intubated patients:

  • PREFERRED: Tight-fitting mask with manual resuscitator bag. Occlude any vents on mask. Use masks with rubber gaskets for best seal.
  • ALTERNATIVE: Mouth-to-snout ventilation ONLY if no zoonotic disease risk. Compression-to-ventilation ratio: 30 compressions to 2 breaths.
  • If unsafe: Perform compression-only CPR
NAVLE TipThe 2024 guidelines updated ventilation recommendations for non-intubated patients. Bag-mask ventilation is now prioritized over mouth-to-snout due to concerns about zoonotic disease transmission (especially relevant post-COVID). This is a change from 2012 guidelines and may appear on NAVLE questions testing knowledge of current best practices.
Drug Dose Indication Notes
Epinephrine 0.01 mg per kg IV or IO BOTH shockable and non-shockable rhythms. Give every 3-5 minutes. NEW 2024: High-dose epinephrine (0.1 mg per kg) is NO LONGER recommended
Vasopressin 0.8 units per kg IV or IO (single dose) Alternative vasopressor for refractory VF or pulseless VT One-time dose only. Potent vasoconstrictor without beta-agonist effects.
Atropine 0.04 mg per kg IV or IO Asystole or PEA with suspected vagal tone NEW 2024: Single dose only (not repeated). High doses associated with poor outcomes.
Reversal Agents Naloxone, flumazenil, atipamezole - per drug-specific dosing CPA secondary to opioid, benzodiazepine, or alpha-2 agonist overdose Administer if known overdose is cause of CPA
Calcium Gluconate 50 to 100 mg per kg IV slow Documented hypocalcemia or hyperkalemia NOT routine. Only if specific indication present.
Sodium Bicarbonate 1 mEq per kg IV Documented severe metabolic acidosis or prolonged CPR NOT routine. May worsen intracellular acidosis if given too early.

Advanced Life Support (ALS)

Advanced Life Support encompasses interventions beyond basic CPR, including drug therapy, defibrillation, and treatment of underlying causes. ALS is initiated once BLS is established and additional personnel are available.

Drug Therapy

Vascular access:

  • PREFERRED: Intravenous (IV) catheter if already placed or can be placed within 2 minutes
  • ALTERNATIVE: Intraosseous (IO) catheter if IV access not achievable. Sites: proximal humerus, proximal femur, tibial crest
  • LEAST PREFERRED: Intratracheal (IT) route for lipophilic drugs only (epinephrine, atropine, naloxone, vasopressin). Dose is 2 to 3 times IV dose.

Defibrillation

Electrical defibrillation is the ONLY definitive treatment for ventricular fibrillation (VF) and pulseless ventricular tachycardia (VT). The 2024 guidelines emphasize that defibrillation should precede epinephrine administration for shockable rhythms.

Defibrillation protocol:

  • Biphasic defibrillator: PREFERRED over monophasic
  • Energy dose: 4 to 6 joules per kg for external defibrillation, 0.5 to 1 joule per kg for internal defibrillation
  • Single-shock therapy: Deliver one shock, then immediately resume compressions (minimizes interruption)
  • If VF/VT less than 4 minutes duration: Immediate defibrillation
  • If VF/VT greater than 4 minutes duration: Perform 2-minute BLS cycle FIRST to improve coronary perfusion, THEN defibrillate
NAVLE TipA key 2024 update: For shockable rhythms, defibrillation now takes priority over epinephrine administration. The sequence is: Recognize VF/VT → Defibrillate (or BLS for 2 minutes then defibrillate if greater than 4 minutes) → Resume compressions immediately → Give epinephrine. This differs from treating non-shockable rhythms where epinephrine comes first.
Parameter Goals and Interventions
Blood Pressure Target: Mean arterial pressure 80-100 mm Hg, or systolic greater than 100 mm Hg. Treat hypotension with fluids, vasopressors, or inotropes as indicated.
Ventilation Maintain normocarbia. Avoid hyperventilation (worsens cerebral vasoconstriction) and hypoventilation (worsens acidosis). Target ETCO2: 35-45 mm Hg.
Oxygenation Maintain adequate oxygenation but avoid hyperoxia. Target SpO2: 94-98 percent.
Temperature Slow rewarming if hypothermic (less than 1 degree Celsius per hour). Avoid hyperthermia (greater than 39 degrees Celsius). Passive warming preferred.
Glucose Avoid both hypoglycemia (less than 60 mg per dL) and hyperglycemia (greater than 180 mg per dL). Monitor closely.
Seizures Treat seizures aggressively with benzodiazepines (midazolam 0.1-0.3 mg per kg IV) or levetiracetam (30-50 mg per kg IV).
Acid-Base Monitor lactate (normal less than 2 mmol per L). Progressive lactate clearance is favorable. Severe acidosis (pH less than 7.1) may require bicarbonate.

Monitoring During CPR

End-Tidal CO2 (ETCO2)

End-tidal CO2 monitoring is the MOST important parameter for assessing CPR quality and detecting return of spontaneous circulation (ROSC). ETCO2 reflects cardiac output and pulmonary blood flow.

ETCO2 targets and interpretation:

  • During CPR: Target ETCO2 greater than or equal to 18 mm Hg. Higher values correlate with improved ROSC and survival.
  • ETCO2 less than 10 mm Hg: Indicates inadequate compressions. Improve depth, rate, or hand placement.
  • Confirming intubation: ETCO2 greater than or equal to 12 mm Hg confirms appropriate endotracheal tube placement (but low ETCO2 does not rule out correct placement).
  • Sudden increase in ETCO2: ROSC has occurred. Stop compressions and assess pulse.

Other Monitoring Parameters

  • Electrocardiography (ECG): Essential for rhythm diagnosis. Check rhythm only during 2-minute cycle breaks to minimize interruptions.
  • Direct blood pressure: Arterial line if available. Target diastolic pressure greater than 20 mm Hg during CPR.
  • NOT recommended: Pulse oximetry and arterial blood gases (require pulsatile flow, unreliable during CPR)

Post-Cardiac Arrest Care

The majority of dogs achieving ROSC will either re-arrest or require euthanasia due to post-cardiac arrest syndrome. Approximately 68 percent of dogs experience re-arrest within hours of initial ROSC. Aggressive post-arrest management is essential.

Post-Cardiac Arrest Syndrome

Post-cardiac arrest syndrome consists of four key components:

  • Post-cardiac arrest myocardial dysfunction: Transient but significant decrease in contractility
  • Post-cardiac arrest brain injury: Anoxic-ischemic injury with potential for delayed neuronal death
  • Systemic ischemia-reperfusion response: Systemic inflammatory response syndrome (SIRS), multiorgan dysfunction
  • Persistent precipitating pathology: The original cause of CPA (sepsis, trauma, cardiac disease)

Management priorities:

Prognosis and Prognostic Factors

Survival Statistics

Overall prognosis for CPA in dogs remains poor despite optimal CPR:

  • Return of spontaneous circulation (ROSC): 35-58 percent of dogs achieve ROSC
  • Survival to discharge: Only 5-7 percent of dogs survive to hospital discharge
  • Re-arrest rate: Approximately 68 percent of dogs re-arrest within hours of achieving ROSC

Favorable Prognostic Factors

  • Anesthesia-related CPA: 17 times more likely to survive to discharge compared to other causes
  • Witnessed arrest with immediate CPR
  • Reversible underlying cause (vagal event, drug overdose, airway obstruction)
  • Short duration of CPA (less than 5 minutes to ROSC)
  • Higher ETCO2 during CPR (greater than 18 mm Hg)
  • Cats (5 times more likely to survive than dogs)
  • Adherence to RECOVER guidelines (improved ROSC rates demonstrated in studies)

Unfavorable Prognostic Factors

  • Advanced neoplasia
  • Sepsis
  • Severe trauma
  • End-stage organ disease
  • Prolonged CPR (greater than 10 minutes)
  • Low ETCO2 during CPR (less than 10 mm Hg)
  • Multiple re-arrest episodes

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →